Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2014

01-06-2014 | Brief Report

Are chlorhexidine-containing dressings safe for use with ventricular drainages?

Authors: S. Scheithauer, M. Möller, A. Höllig, G. Marx, S. Thoröe, L. Lopez-Gonzalez, M. H. T. Reinges, S. W. Lemmen

Published in: Infection | Issue 3/2014

Login to get access

Abstract

The purpose of this report was to assess the safety and application of chlorhexidine (CHG)-containing dressings—shown to reduce central line infection rates markedly—for external ventricular drainages (EVDs) and lumbar drainages (LDs). Cerebrospinal fluid samples of patients receiving standard dressings and CHG-containing dressing (ten each) were analyzed by high-performance liquid chromatography for the presence of CHG. The application was evaluated. CHG was not detectable in all samples. The dressings’ application for EVDs and LDs worked without problems. Thus, the use of CHG-containing dressings for EVDs and LDs seems to be safe. Further studies addressing their infection reduction potential are warranted.
Literature
1.
Lozier AP, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170–81.PubMedCrossRef
2.
Scheithauer S, Bürgel U, Ryang YM, et al. Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2009;80:1381–5.PubMedCrossRef
3.
Scheithauer S, Bürgel U, Bickenbach J, et al. External ventricular and lumbar drainage-associated meningoventriculitis: prospective analysis of time-dependent infection rates and risk factor analysis. Infection. 2010;38:205–9.PubMedCrossRef
4.
Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301:1231–41.PubMedCrossRef
5.
Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186:1272–8.PubMedCrossRef
6.
Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46:274–81.PubMedCrossRef
7.
Henschen A, Olson L. Chlorhexidine-induced degeneration of adrenergic nerves. Acta Neuropathol. 1984;63:18–23.PubMedCrossRef
8.
Olson L, Björklund H, Henschen A, et al. Some toxic effects of lead, other metals and antibacterial agents on the nervous system—animal experiment models. Acta Neurol Scand Suppl. 1984;100:77–87.PubMed
9.
Bicknell PG. Sensorineural deafness following myringoplasty operations. J Laryngol Otol. 1971;85:957–61.PubMedCrossRef
10.
O’Connor M. Responsiveness to the chlorhexidine epidural tragedy: a mental block? J Law Med. 2012;19:436–43.PubMed
11.
Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58:281–7.PubMedCrossRef
12.
Xue Y, Tang M, Hieda Y, et al. High-performance liquid chromatographic determination of chlorhexidine in whole blood by solid-phase extraction and kinetics following an intravenous infusion in rats. J Anal Toxicol. 2009;33:85–91.PubMedCrossRef
13.
Metadata
Title
Are chlorhexidine-containing dressings safe for use with ventricular drainages?
Authors
S. Scheithauer
M. Möller
A. Höllig
G. Marx
S. Thoröe
L. Lopez-Gonzalez
M. H. T. Reinges
S. W. Lemmen
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0596-2

Other articles of this Issue 3/2014

Infection 3/2014 Go to the issue

Clinical and Epidemiological Study

Infections in patients hospitalized for fever as related to duration and other predictors at admittance

Case Report

Mycobacterium avium-intracellulare pulmonary infection complicated by cutaneous leukocytoclastic vasculitis in a woman with anorexia nervosa

Case Report

Pulmonary toxocariasis: a case report and literature review

Brief Report

tst1-positive ST22-MRSA-IVa in healthy Italian preschool children

Correspondence

Tolerance and safety of intravenous streptomycin therapy in patients with tuberculosis

Case Report

A case report and literature overview: Abiotrophia defectiva aortic valve endocarditis in developing countries
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits